These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27560170)
1. A high-yield double-purification proteomics strategy for the identification of SUMO sites. Hendriks IA; Vertegaal AC Nat Protoc; 2016 Sep; 11(9):1630-49. PubMed ID: 27560170 [TBL] [Abstract][Full Text] [Related]
2. Label-Free Identification and Quantification of SUMO Target Proteins. Hendriks IA; Vertegaal AC Methods Mol Biol; 2016; 1475():171-93. PubMed ID: 27631806 [TBL] [Abstract][Full Text] [Related]
3. Site-specific identification and quantitation of endogenous SUMO modifications under native conditions. Lumpkin RJ; Gu H; Zhu Y; Leonard M; Ahmad AS; Clauser KR; Meyer JG; Bennett EJ; Komives EA Nat Commun; 2017 Oct; 8(1):1171. PubMed ID: 29079793 [TBL] [Abstract][Full Text] [Related]
4. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif. Matic I; Schimmel J; Hendriks IA; van Santen MA; van de Rijke F; van Dam H; Gnad F; Mann M; Vertegaal AC Mol Cell; 2010 Aug; 39(4):641-52. PubMed ID: 20797634 [TBL] [Abstract][Full Text] [Related]
5. Proteome-wide identification of SUMO modification sites by mass spectrometry. Tammsalu T; Matic I; Jaffray EG; Ibrahim AF; Tatham MH; Hay RT Nat Protoc; 2015 Sep; 10(9):1374-88. PubMed ID: 26292070 [TBL] [Abstract][Full Text] [Related]
7. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction. Cooper HJ; Tatham MH; Jaffray E; Heath JK; Lam TT; Marshall AG; Hay RT Anal Chem; 2005 Oct; 77(19):6310-9. PubMed ID: 16194093 [TBL] [Abstract][Full Text] [Related]
8. Different proteomic strategies to identify genuine Small Ubiquitin-like MOdifier targets and their modification sites in Trypanosoma brucei procyclic forms. Iribarren PA; Berazategui MA; Bayona JC; Almeida IC; Cazzulo JJ; Alvarez VE Cell Microbiol; 2015 Oct; 17(10):1413-22. PubMed ID: 26096196 [TBL] [Abstract][Full Text] [Related]
19. SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer. Lopitz-Otsoa F; Delgado TC; Lachiondo-Ortega S; Azkargorta M; Elortza F; Rodríguez MS; Martínez-Chantar ML J Vis Exp; 2019 Nov; (153):. PubMed ID: 31736480 [TBL] [Abstract][Full Text] [Related]
20. A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Galisson F; Mahrouche L; Courcelles M; Bonneil E; Meloche S; Chelbi-Alix MK; Thibault P Mol Cell Proteomics; 2011 Feb; 10(2):M110.004796. PubMed ID: 21098080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]